Article thumbnail

Stereocomplexes Formed From Select Oligomers of Polymer d-lactic Acid (PDLA) and l-lactate May Inhibit Growth of Cancer Cells and Help Diagnose Aggressive Cancers—Applications of the Warburg Effect

By Joel S. Goldberg


It is proposed that select oligomers of polymer d-lactic acid (PDLA) will form a stereocomplex with l-lactate in vivo, producing lactate deficiency in tumor cells. Those cancer cells that utilize transport of lactate to maintain electrical neutrality may cease to multiply or die because of lactate trapping, and those cancer cells that benefit from utilization of extracellular lactate may be impaired. Intracellular trapping of lactate produces a different physiology than inhibition of LDH because the cell loses the option of shuttling pyruvate to an alternative pathway to produce an anion. Conjugated with stains or fluorescent probes, PDLA oligomers may be an agent for the diagnosis of tissue lactate and possibly cell differentiation in biopsy specimens. Preliminary experimental evidence is presented confirming that PDLA in high concentrations is cytotoxic and that l-lactate forms a presumed stereocomplex with PDLA. Future work should be directed at isolation of biologically active oligomers of PDLA

Topics: Perspective
Publisher: Libertas Academica
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth.
  2. (2006). Acidmediated tumor invasion: a multidisciplinary study. Cancer Res.
  3. (2010). Anti-cancer drugs that target metabolism, is dichloroacetate the new paradigm?
  4. (2010). Anticonvulsant and proconvulsant actions of 2-deoxy-D-glucose. Epilepsia.
  5. Aswath PB. Microwave synthesis of poly(L-lactic acid).
  6. (2004). Biodegradable dextran hydrogels crosslinked by stereocomplex formation for the controlled release of pharmaceutical proteins.
  7. (2007). Biodegradable dextran hydrogels for protein delivery applications. Expert Rev Med Devices.
  8. Biopolymer stereocomplexes. Adv Drug Deliv Rev.
  9. Cancer as a metabolic disease. Nutr Metab (Lond).
  10. (2009). Cell-cell and intracellular lactate shuttles.
  11. (2003). Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev.
  12. (2000). Controlled release of liposomes from biodegradable dextran microspheres: a novel delivery concept. Pharm Res.
  13. (1997). Correlation of high lactate levels in head and neck tumors with incidence of metastasis.
  14. Correlation of high lactate levels in human cervical cancer with incidence of metastasis.
  15. (2009). Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro.
  16. (1998). D-lactic acidosis. A review of clinical presentation, biochemical features, and pathophysiologic mechanisms. Medicine
  17. (2005). D-lactic acidosis. Nutr Clin Pract.
  18. Del Carpio CA. In vitro hydrolysis of blends from enantiomeric poly(lactide)s. 3. Homocrystallized and amorphous blend films.
  19. Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells.
  20. Differential responses of tumors and normal brain to the combined treatment of 2-DG and radiation in glioablastoma.
  21. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer.
  22. Enhancement of radionuclide induced cytotoxicity by 2-deoxy-D-glucose in human tumor cell lines.
  23. Enzymatic hydrolysis of poly(lactide)s: effects of molecular weight, L-lactide content, and enantiomeric and diastereoisomeric polymer blending.
  24. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev.
  25. Glycolysis in cancer: a potential target for therapy.
  26. Glycolysis inhibition for anticancer treatment.
  27. (1989). Hereditary complete deficiency of lactate dehydrogenase H-subunit. Clin Chem.
  28. Hereditary deficiency of lactate dehydrogenase H-subunit.
  29. (1980). Hereditary deficiency of lactate dehydrogenase M-subunit. Clin Chim Acta.
  30. Hetero-stereocomplexes of D-poly(lactic acid) and the LHRH analogue leuprolide. Application in controlled release.
  31. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res.
  32. (2003). IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.
  33. (2003). In vitro hydrolysis of blends from enantiomeric poly(lactide)s. Part 4: well-homo-crystallized blend and nonblended films.
  34. (2004). In vitro hydrolysis of poly(L-lactide) crystalline residues as extended-chain crystallites. Part I: long-term hydrolysis in phosphatebuffered solution at 37 degrees
  35. (2008). Macroscopic hydrogels by self-assembly of oligolactate-grafted dextran microspheres.
  36. Metabolic mapping with bioluminescence: basic and clinical relevance.
  37. Metabolic modulation of glioblastoma with dichloroacetate. Sci Transl Med.
  38. (2009). Monocarbgoxylate transporter 1. UCSD-Nature Molecule Pages.
  39. Monodisperse enantiomeric lactic acid oligomers: Preparation, characterization, and stereocomplex formation.
  40. Phase II evaluation of Lonidamine in patients with advanced malignancy.
  41. Poly(lactide) stereocomplexes: formation, structure, properties, degradation, and applications.
  42. (2002). Stereocomplexes based on poly(lactic acid) and insulin: formulation and release studies.
  43. (1998). Tannock IF. The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase.
  44. (2004). Targeting intracellular targets. Curr Drug Deliv.
  45. (2008). The genomic analysis of lactic acidosis and acidosis response in human cancers. PLoS Genet.
  46. The Metabolism of Tumors in the Body.
  47. (2005). Tissue reactions of in situ formed dextran hydrogels crosslinked by stereocomplex formation after subcutaneous implantation in rats. Biomaterials.
  48. (2010). Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation. Future Oncol.
  49. (2004). Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol.
  50. (2006). Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol Cancer Ther.